Literature DB >> 15893636

Rotenone induces aggregation of gamma-tubulin protein and subsequent disorganization of the centrosome: relevance to formation of inclusion bodies and neurodegeneration.

F J Diaz-Corrales1, M Asanuma, I Miyazaki, K Miyoshi, N Ogawa.   

Abstract

Neurodegenerative disorders are characterized by progressive loss of specific neurons in the central nervous system. Although they have different etiologies and clinical manifestations, most of them share similar histopathologic characteristics such as the presence of inclusion bodies in both neurons and glial cells, which represent intracellular aggregation of misfolded or aberrant proteins. In Parkinson's disease, formation of inclusion bodies has been associated with the aggresome-related process and consequently with the centrosome. However, the significance of the centrosome in the neurodegenerative process remains obscure. In the present study, the morphological and functional changes in the centrosome induced by rotenone, a common insecticide used to produce experimental Parkinsonism, were examined both in vitro and in vivo. Aggregation of gamma-tubulin protein, which is a component of the centrosome matrix and recently identified in Lewy bodies of Parkinson's disease, was observed in primary cultures of mesencephalic cells treated with rotenone. Rotenone-treated neurons and astrocytes showed enlarged and multiple centrosomes. These centrosomes also displayed multiple aggregates of alpha-synuclein protein. Neurons with disorganized centrosomes exhibited neurite retraction and microtubule destabilization, and astrocytes showed disturbances of mitotic spindles. The Golgi apparatus, which is closely related to the centrosome, was dispersed in both rotenone-treated neuronal cells and the substantia nigra of rotenone-treated rats. Our findings suggested that recruitment of abnormal proteins in the centrosome contributed to the formation of inclusion bodies, and that rotenone markedly affected the structure and function of the centrosome with consequent induction of cytoskeleton disturbances, disassembly of the Golgi apparatus and collapse of neuronal cells.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15893636     DOI: 10.1016/j.neuroscience.2005.01.044

Source DB:  PubMed          Journal:  Neuroscience        ISSN: 0306-4522            Impact factor:   3.590


  16 in total

Review 1.  Comparative Microarray Analysis Identifies Commonalities in Neuronal Injury: Evidence for Oxidative Stress, Dysfunction of Calcium Signalling, and Inhibition of Autophagy-Lysosomal Pathway.

Authors:  Yann Wan Yap; Roxana M Llanos; Sharon La Fontaine; Michael A Cater; Philip M Beart; Nam Sang Cheung
Journal:  Neurochem Res       Date:  2015-08-29       Impact factor: 3.996

Review 2.  Ubiquitin/proteasome pathway impairment in neurodegeneration: therapeutic implications.

Authors:  Qian Huang; Maria E Figueiredo-Pereira
Journal:  Apoptosis       Date:  2010-11       Impact factor: 4.677

Review 3.  Environmental neurotoxicant-induced dopaminergic neurodegeneration: a potential link to impaired neuroinflammatory mechanisms.

Authors:  Arthi Kanthasamy; Huajun Jin; Adhithiya Charli; Anantharam Vellareddy; Anumantha Kanthasamy
Journal:  Pharmacol Ther       Date:  2019-01-22       Impact factor: 12.310

4.  Protective effects of curcumin against rotenone-induced rat model of Parkinson's disease: in vivo electrophysiological and behavioral study.

Authors:  L V Darbinyan; L E Hambardzumyan; K V Simonyan; V A Chavushyan; L P Manukyan; S A Badalyan; N Khalaji; V H Sarkisian
Journal:  Metab Brain Dis       Date:  2017-07-10       Impact factor: 3.584

5.  Novel role for mitochondria: protein kinase Ctheta-dependent oxidative signaling organelles in activation-induced T-cell death.

Authors:  Marcin Kaminski; Michael Kiessling; Dorothee Süss; Peter H Krammer; Karsten Gülow
Journal:  Mol Cell Biol       Date:  2007-03-05       Impact factor: 4.272

6.  Dopamine induces supernumerary centrosomes and subsequent cell death through Cdk2 up-regulation in dopaminergic neuronal cells.

Authors:  Francisco J Diaz-Corrales; Masato Asanuma; Ikuko Miyazaki; Ko Miyoshi; Nobutaka Hattori; Norio Ogawa
Journal:  Neurotox Res       Date:  2008-12       Impact factor: 3.911

7.  Methionine sulfoxide reductase A protects dopaminergic cells from Parkinson's disease-related insults.

Authors:  Fang Liu; Jagadish Hindupur; Jamie L Nguyen; Katie J Ruf; Junyi Zhu; Jeremy L Schieler; Connie C Bonham; Karl V Wood; V Jo Davisson; Jean-Christophe Rochet
Journal:  Free Radic Biol Med       Date:  2008-04-11       Impact factor: 7.376

8.  Golgi fragmentation is Rab and SNARE dependent in cellular models of Parkinson's disease.

Authors:  Wilson O Rendón; Emma Martínez-Alonso; Mónica Tomás; Narcisa Martínez-Martínez; José A Martínez-Menárguez
Journal:  Histochem Cell Biol       Date:  2012-12-02       Impact factor: 4.304

9.  Stress-induced localization of HSPA6 (HSP70B') and HSPA1A (HSP70-1) proteins to centrioles in human neuronal cells.

Authors:  Sam Khalouei; Ari M Chow; Ian R Brown
Journal:  Cell Stress Chaperones       Date:  2013-09-06       Impact factor: 3.667

10.  The parkinsonian neurotoxin rotenone activates calpain and caspase-3 leading to motoneuron degeneration in spinal cord of Lewis rats.

Authors:  S Samantaray; V H Knaryan; M K Guyton; D D Matzelle; S K Ray; N L Banik
Journal:  Neuroscience       Date:  2007-03-23       Impact factor: 3.590

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.